ID
int64
1
9.11k
age
float64
18
102
death
int64
0
1
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
d.time
int64
3
2.03k
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
701
71.745
1
female
0
5
328
CHF
COPD/CHF/Cirrhosis
3
16
$11-$25k
0
9,478
5,019.3398
null
14
white
23.898438
38
0.78894
0.660889
1
1
0
no
0.95
0.8
dnr after sadm
1
53
11.5
82
20
36.39844
null
null
null
2.099609
139
null
null
null
null
null
null
adl>=4 (>=5 if sur)
2.544922
702
65.93298
1
female
0
4
715
CHF
COPD/CHF/Cirrhosis
2
13
under $11k
0
10,227
5,117.5234
null
10
asian
20.796875
30
0.810913
0.69397
8
0
0
no
0.75
0.5
no dnr
4
103
8.699219
134
24
36
260.8125
null
null
1
141
7.459961
null
null
null
null
3
no(M2 and SIP pres)
3
703
69.98199
1
female
0
15
680
CHF
COPD/CHF/Cirrhosis
1
12
under $11k
100
65,732
33,516.375
null
34
black
28
43
0.217987
0.069992
3
0
0
no
0.06
0.000216
no dnr
15
63
11.199219
110
26
36.5
241.65625
3.299805
2.699707
1.5
130
7.389648
null
null
null
null
7
adl>=4 (>=5 if sur)
7
704
82.14099
1
male
0
20
65
MOSF w/Malig
ARF/MOSF
1
null
null
26
113,460
56,403.9375
null
15
black
23
32
0.402954
0.283997
12
0
0
metastatic
0.8
0.5
dnr after sadm
12
75
9.199219
70
22
36.5
107.14062
3.599609
0.299988
1.299805
133
7.5
null
null
null
null
null
null
4.479492
705
41.06198
0
female
0
4
1,419
ARF/MOSF w/Sepsis
ARF/MOSF
1
15
$11-$25k
0
16,536
8,055.3008
null
6
black
18.898438
9
0.914917
0.883911
1
0
0
no
0.9
0.85
no dnr
4
117
16.898438
74
24
37
218.34375
null
null
1
130
7.379883
null
null
null
null
null
null
2.039551
706
56.34998
1
female
0
3
1,344
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
0
4,944
2,253.7129
null
6
white
20.597656
12
0.892944
0.820923
1
0
0
no
null
null
no dnr
3
87
6.699219
100
24
37
266.625
null
null
0.599976
130
7.439453
null
null
null
0
null
no(M2 and SIP pres)
0.4948
707
67.72894
1
male
0
9
1,325
CHF
COPD/CHF/Cirrhosis
3
18
$11-$25k
0
32,258
16,843.2656
null
10
white
15.298828
20
0.897949
0.828979
1
0
0
no
0.96
0.92
no dnr
9
110
7.599609
65
24
36.5
null
null
0.799927
1.299805
137
null
null
null
null
null
null
null
2.985352
708
51.18698
1
male
0
10
1,243
Colon Cancer
Cancer
3
null
null
0
30,006
15,566.1562
null
11.5
white
23.097656
39
0.75293
0.493958
1
1
0
metastatic
0.1
0.001
no dnr
10
120
11.398438
140
20
39.5
null
null
0.299988
1.699951
135
null
null
null
null
null
null
null
3.51709
709
48.43799
1
male
1
11
11
MOSF w/Malig
ARF/MOSF
1
15
>$50k
0
275,297
131,152.125
null
38.5
white
49.5
93
0.023998
0.006
27
0
0
yes
null
null
dnr after sadm
9
58
0.599976
170
26
39.89844
56
2.599609
0.599976
3.599609
150
7.329102
null
null
null
null
null
<2 mo. follow-up
2.244629
710
63.573
1
female
1
32
32
MOSF w/Malig
ARF/MOSF
1
12
$25-$50k
26
231,839
99,332.375
null
30.75
white
34.898438
34
0.128998
0.058998
7
0
0
metastatic
0.75
0.2
dnr after sadm
18
60
4.099609
130
23
38.69531
107.6875
2
0.599976
0.899902
125
7.419922
null
null
null
null
null
<2 mo. follow-up
3.240234
711
56.74197
1
male
0
12
738
Colon Cancer
Cancer
1
18
$11-$25k
0
41,129
20,834.9062
null
12.5
white
5.199219
11
0.931885
0.839966
1
0
0
metastatic
0.95
0.85
no dnr
12
98
10.599609
82
20
36.39844
null
4.399414
0.699951
1.099854
136
null
null
null
null
null
0
no(M2 and SIP pres)
0
712
52.43799
0
male
0
17
1,411
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
73,122
36,176.8438
null
22.333328
white
19.296875
19
0.890991
0.816895
2
1
0
no
0.85
0.8
no dnr
17
67
6.299805
110
22
36.39844
457.125
null
null
0.899902
134
7.489258
null
null
null
0
0
no(M2 and SIP pres)
0
713
73.59094
1
female
0
124
200
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
37
null
352,231.25
null
34.25
white
30.398438
49
0.379944
0.261963
11
0
0
no
null
null
no dnr
124
68
27.5
110
12
38.5
90.90625
2.399902
2.399902
1.099854
131
7.419922
null
null
null
null
null
adl>=4 (>=5 if sur)
2.776367
714
56.50098
1
male
1
7
7
Cirrhosis
COPD/CHF/Cirrhosis
2
12
null
41
95,243
48,038.875
null
26.5
white
32.796875
54
0.22699
0.074997
15
0
0
no
0.1
0.001
dnr after sadm
7
123
16.898438
115
9
37
273.3125
3.599609
11.398438
5.899414
137
7.439453
null
null
null
null
6
<2 mo. follow-up
6
715
45.22699
0
male
0
29
1,406
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
37
213,989
110,645.438
null
27.5
white
23.398438
21
0.754883
0.67688
4
0
0
no
null
null
no dnr
29
122
18.5
120
6
37.29688
504
null
null
0.699951
132
7.489258
null
null
null
null
null
null
3.437012
716
54.44498
1
male
1
5
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
18
>$50k
41
61,442
28,589.9844
null
42
white
58.695313
81
0.003
0
2
0
0
no
0.1
0.001
no dnr
5
30
6.799805
145
20
39.19531
81
2.199707
12.699219
0.599976
131
7.349609
null
null
null
null
null
<2 mo. follow-up
2.519531
717
85.36096
1
male
1
3
3
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
null
100
51,486
24,927.7031
null
33
white
44.296875
76
0
0
9
0
0
no
0.01
0.000001
no dnr
3
40
18.097656
30
25
38
294
null
2.5
2.699707
131
7.229492
null
null
null
null
0
<2 mo. follow-up
0
718
46.08099
0
male
0
31
1,405
CHF
COPD/CHF/Cirrhosis
2
14
under $11k
0
170,570
84,744.75
null
17
hispanic
15.099609
12
0.93689
0.891968
1
0
0
no
null
null
no dnr
31
67
null
50
16
37.79688
null
null
0.199982
0.899902
138
null
null
null
null
0
1
no(M2 and SIP pres)
1
719
32.42697
1
female
1
10
10
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
under $11k
100
382,471
201,105.75
null
45.5
white
43.09375
98
0.045998
0.014
13
0
0
no
0.1
0.001
dnr after sadm
9
57
39.796875
120
36
35.09375
205.6875
1.799805
16.898438
2.199707
134
7.399414
null
null
null
null
null
<2 mo. follow-up
4.032227
720
66.27496
1
male
0
8
879
Colon Cancer
Cancer
1
20
>$50k
0
18,606
9,488.0312
null
9
white
18.597656
11
0.791992
0.56189
1
0
0
metastatic
null
null
no dnr
8
83
13.398438
68
20
38
null
3.199707
1.399902
1.099854
135
null
null
null
null
0
null
null
0.4948
721
78.53796
1
female
0
6
146
COPD
COPD/CHF/Cirrhosis
2
16
$25-$50k
0
8,697
5,066.1602
null
7
white
21.097656
28
0.775879
0.641968
1
0
0
no
0.9
0.85
no dnr
6
96
12.199219
96
22
36
157.125
3.699707
0.599976
1.199951
142
7.399414
null
null
null
null
0
no(M2 and SIP pres)
0
722
50.95099
1
female
1
43
43
MOSF w/Malig
ARF/MOSF
1
12
null
26
449,923
199,117.25
null
41.75
black
27.296875
47
0.530884
0.415955
1
0
0
yes
null
null
no dnr
43
63
19.398438
125
14
39.39844
234
2.899902
1.399902
6.599609
144
7.40918
null
null
null
null
0
<2 mo. follow-up
0
723
39.81897
1
male
1
5
5
ARF/MOSF w/Sepsis
ARF/MOSF
2
13
null
100
54,871
26,152.2031
null
40
white
60.5
102
0
0
3
0
0
no
0.1
0.001
no dnr
5
35
18.398438
130
15
38.79688
100
2.099609
20.296875
3
132
7.30957
null
null
null
null
null
<2 mo. follow-up
3.381348
724
31.34299
1
female
1
11
11
Coma
Coma
1
null
null
100
148,727
66,520.625
null
28
white
47.59375
62
0
0
32
0
0
metastatic
null
null
no dnr
11
42
20.199219
140
20
38.5
68
null
null
2.299805
132
7.339844
null
null
null
null
null
<2 mo. follow-up
3.606934
725
73.14697
1
male
0
11
971
CHF
COPD/CHF/Cirrhosis
2
4
>$50k
0
20,810
13,290.375
null
9.5
white
21
39
0.823975
0.712891
1
0
0
no
null
null
no dnr
11
70
8.599609
65
28
36
null
null
null
2
138
null
null
null
null
null
4
no(M2 and SIP pres)
4
726
73.70294
1
male
0
7
166
CHF
COPD/CHF/Cirrhosis
1
24
null
0
14,284
8,644.1797
null
8
white
20.296875
45
0.830933
0.723999
1
0
0
no
null
null
no dnr
7
77
5.299805
92
28
38.09375
261.875
null
2.299805
2.199707
137
7.479492
null
null
null
0
null
no(M2 and SIP pres)
0.4948
727
71.75397
0
female
0
25
1,400
COPD
COPD/CHF/Cirrhosis
1
9
under $11k
26
135,615
60,638.9062
null
22.5
black
18.097656
15
0.794922
0.670898
1
0
0
no
0.6
0.5
no dnr
25
60
15.398438
110
10
38.19531
300
2.799805
null
0.899902
137
7.439453
null
null
null
null
null
no(M2 and SIP pres)
2.896973
728
63.59799
1
male
1
4
4
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
44
51,942
23,758.9062
null
39
white
69.390625
100
0
0
1
0
0
yes
0.1
0.001
dnr after sadm
2
30
50.59375
115
25
38.39844
56
2.5
22.796875
5.199219
129
7.579102
null
null
null
null
null
<2 mo. follow-up
2.206543
729
72.323
1
male
0
18
66
Colon Cancer
Cancer
2
null
null
0
36,244
20,509.875
null
11.333328
white
28.597656
19
0.569946
0.247986
1
1
0
metastatic
0.6
0.2
dnr after sadm
9
81
16.296875
112
20
39.19531
null
3.099609
null
0.799927
128
null
null
null
null
null
null
null
3.349121
730
44.12299
1
female
0
28
55
MOSF w/Malig
ARF/MOSF
2
12
null
41
293,158
148,681.25
null
19.25
white
37.59375
71
0.084
0.031998
23
0
0
yes
0.5
0.5
no dnr
28
63
3.399902
160
21
39.19531
348
null
9
4.899414
135
7.40918
null
null
null
null
0
<2 mo. follow-up
0
731
21.74899
0
male
0
23
1,396
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
under $11k
0
156,314
88,603.3125
null
26.333328
white
19.898438
11
0.92395
0.896973
4
0
0
no
null
null
no dnr
23
70
10.798828
105
20
38.59375
206.09375
null
null
0.799927
145
7.30957
null
null
null
null
0
no(M2 and SIP pres)
0
732
67.85797
1
female
1
19
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
>$50k
0
234,034
109,152.25
null
37.666657
white
21.898438
34
0.771973
0.697998
13
0
0
no
0.8
0.75
dnr after sadm
17
75
6.599609
105
28
36.5
183.3125
2.099609
null
1
144
7.489258
null
null
null
null
0
<2 mo. follow-up
0
733
58.05099
0
female
0
6
1,395
Lung Cancer
Cancer
2
12
null
0
9,864
5,061.0352
null
9
black
16.5
12
0.733887
0.464966
1
0
0
metastatic
0.9
0.75
no dnr
6
79
10.298828
100
24
37.39844
null
null
null
0.899902
137
null
null
null
null
null
null
no(M2 and SIP pres)
2.530273
734
57.84799
1
male
1
4
4
MOSF w/Malig
ARF/MOSF
1
14
$25-$50k
55
139,623
68,361.5
null
58
white
57.796875
104
0
0
18
0
0
yes
0.07
0.000343
no dnr
4
48
0.049995
200
32
39.29688
75.54688
null
8.699219
1.799805
152
7.289062
null
null
null
null
5
<2 mo. follow-up
5
735
72.56097
1
male
1
28
28
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
$25-$50k
9
301,990
138,869.5
null
26.5
white
38.898438
57
0.181
0.093994
21
0
0
yes
0.5
0.125
dnr after sadm
22
70
15.798828
110
22
36.09375
190
3.299805
26.296875
2.399902
135
7.469727
null
null
null
null
1
<2 mo. follow-up
1
736
49.53
0
female
0
4
1,392
CHF
COPD/CHF/Cirrhosis
3
11
under $11k
0
10,545
5,904.1562
null
10
black
15.699219
21
0.927979
0.878906
1
1
0
no
1
0.95
no dnr
4
103
6.199219
86
24
36.89844
null
null
null
1.399902
134
null
null
null
null
null
null
no(M2 and SIP pres)
2.237305
737
60.65399
1
male
1
51
51
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
26
475,387
216,298.25
null
35.75
white
30.5
52
0.615967
0.510986
1
1
0
no
null
null
dnr after sadm
44
63
5.199219
125
8
38.89844
114
2.399902
1.5
1.799805
137
7.399414
null
null
null
null
null
<2 mo. follow-up
3.022461
738
69.41797
1
male
1
4
4
Lung Cancer
Cancer
1
14
$11-$25k
0
7,194
3,058.4688
null
12
asian
26.898438
33
0.445984
0.134979
1
0
0
metastatic
null
null
dnr after sadm
2
73
null
62
34
39.19531
128.5625
3.099609
0.299988
1.099854
133
7.479492
null
null
null
null
6
<2 mo. follow-up
6
739
25.89699
0
male
0
28
1,391
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
251,227
126,467.875
null
22.5
hispanic
33
36
0.691895
0.600952
16
0
0
yes
0.75
0.7
no dnr
28
153
7.099609
110
24
35.89844
76
2.799805
0.799927
2.199707
136
7.389648
null
null
null
null
5
adl>=4 (>=5 if sur)
5
740
47.43298
1
male
1
17
17
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$11-$25k
26
169,364
82,586.5
null
37
white
33.796875
63
0.612915
0.507935
1
0
0
no
0.1
0.001
dnr after sadm
6
73
5.099609
115
24
36.89844
191.65625
2.199707
19.296875
1.699951
141
7.519531
null
null
null
null
null
<2 mo. follow-up
3.063965
741
36.29797
0
male
0
15
1,385
Cirrhosis
COPD/CHF/Cirrhosis
2
12
under $11k
0
48,925
26,166.5
null
10
white
23.597656
18
0.845947
0.746948
2
0
0
no
0.9
0.9
no dnr
15
97
13.5
118
16
38
190
null
3.199707
0.799927
140
7.389648
null
null
null
0
null
null
0.4948
742
63.07999
0
male
0
9
1,384
CHF
COPD/CHF/Cirrhosis
2
14
under $11k
0
29,706
14,753.0078
null
13.5
hispanic
31
44
0.705933
0.544922
1
1
0
no
null
null
no dnr
9
51
5.299805
75
24
36.29688
null
2.5
1.199951
1.299805
128
7.469727
null
null
null
1
3
no(M2 and SIP pres)
3
743
61.77399
1
male
0
9
181
CHF
COPD/CHF/Cirrhosis
2
12
>$50k
0
21,076
12,039.4688
null
16
white
13.699219
16
0.919922
0.86499
1
0
0
no
0.9
0.85
no dnr
9
110
6
70
16
36.59375
null
3.599609
0.699951
1.299805
141
null
null
null
null
0
0
no(M2 and SIP pres)
0
744
55.23297
1
female
1
19
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
9
233,772
97,798.75
null
39.666657
other
27.5
34
0.763916
0.688965
1
1
0
no
null
null
no dnr
19
60
11.298828
115
8
36.39844
230
2.799805
0.799927
1.399902
125
7.489258
null
null
null
null
null
<2 mo. follow-up
2.753906
745
72.42694
1
female
1
9
9
Cirrhosis
COPD/CHF/Cirrhosis
2
null
null
26
69,587
34,518
null
37.5
other
29.097656
47
0.326965
0.142975
2
0
0
no
0.5
0.4
dnr after sadm
8
103
8.398438
135
32
37.69531
172.5
3.099609
4.699219
1.299805
153
7.40918
null
null
null
null
null
<2 mo. follow-up
3.146973
746
80.38599
1
male
0
5
215
Colon Cancer
Cancer
2
8
$25-$50k
0
11,109
6,680.4805
null
9
white
15.398438
25
0.810913
0.594971
1
1
0
metastatic
0.9
0.3
no dnr
5
73
5.599609
72
18
36.19531
null
null
null
1.099854
135
null
null
null
null
0
0
no(M2 and SIP pres)
0
747
74.12695
1
male
1
3
3
Coma
Coma
1
14
under $11k
100
22,541
11,522.2422
null
24
white
22.398438
13
0.166992
0.112
1
0
1
no
null
null
dnr after sadm
3
82
9.699219
50
14
35
430
4.099609
null
0.899902
134
7.479492
null
null
null
null
null
<2 mo. follow-up
4.672852
748
34.32199
1
female
0
40
150
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
$11-$25k
55
271,769
136,256.625
null
26.5
hispanic
28.597656
39
0.638916
0.537964
4
1
0
no
0.8
0.6
no dnr
40
115
13.199219
110
16
39.5
166.65625
null
0.699951
7.399414
136
7.359375
null
null
null
null
6
adl>=4 (>=5 if sur)
6
749
51.491
1
female
1
90
90
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
$11-$25k
37
1,056,280
463,356.75
null
38
white
36
59
0.395996
0.276978
6
0
0
no
null
null
dnr after sadm
88
63
39
135
36
37.09375
220
null
2.699707
3.699707
129
7.5
null
null
null
null
0
adl>=4 (>=5 if sur)
0
750
64.92499
0
female
0
6
1,378
CHF
COPD/CHF/Cirrhosis
3
5
null
0
22,303
10,978.2969
null
23
hispanic
21.699219
29
0.842896
0.741943
1
1
0
no
null
null
no dnr
6
60
7.5
135
28
36.39844
258.3125
null
0.699951
0.799927
142
7.329102
null
null
null
3
3
null
3
751
71.95599
1
male
0
10
137
CHF
COPD/CHF/Cirrhosis
0
null
null
0
35,928
18,626.0938
null
18.5
asian
24.5
38
0.779907
0.647949
1
0
0
no
0.95
0.6
no dnr
10
55
6.199219
105
24
39.19531
null
null
1.199951
1.899902
133
null
null
null
null
null
null
null
2.697266
752
60.59097
0
female
0
12
1,376
Colon Cancer
Cancer
1
12
$25-$50k
0
35,397
18,058.4375
null
12.5
white
4.299805
17
0.93396
0.843994
1
0
0
metastatic
0.95
0.8
no dnr
12
81
7.5
120
22
38.39844
null
4.699219
0.5
1
139
null
null
null
null
null
0
no(M2 and SIP pres)
0
753
33.09
1
male
1
24
24
MOSF w/Malig
ARF/MOSF
0
null
null
55
216,416
96,186.9375
null
31.666656
asian
37.296875
37
0.082993
0.031998
7
0
0
yes
0.1
0.001
no dnr
24
110
3
160
12
35.5
113.84375
null
0.5
0.5
135
7.469727
null
null
null
null
null
<2 mo. follow-up
2.698242
754
74.74896
1
male
0
4
473
CHF
COPD/CHF/Cirrhosis
1
null
null
0
10,758
4,629.7305
null
6
white
16.796875
38
0.866943
0.779907
1
0
0
no
0.9
0.6
no dnr
4
65
5
110
24
36
null
5.5
0.799927
1.5
130
null
null
null
null
null
null
null
2.025391
755
50.90198
1
male
0
13
790
CHF
COPD/CHF/Cirrhosis
2
14
$25-$50k
0
37,558
23,093.8125
null
15.5
white
16.398438
21
0.921997
0.86792
1
0
0
no
0.9
0.75
no dnr
13
68
11
110
20
37.79688
null
4.199219
1.399902
1.299805
132
null
null
null
null
0
0
no(M2 and SIP pres)
0
756
55.866
1
male
0
14
783
CHF
COPD/CHF/Cirrhosis
2
16
$25-$50k
0
68,122
30,441.1719
null
14
white
20
40
0.885986
0.80896
1
0
0
no
0.5
0.5
no dnr
14
70
22.597656
140
20
36
null
4.699219
1.099854
1.899902
138
null
null
null
null
0
0
no(M2 and SIP pres)
0
757
77.396
0
male
0
6
1,375
CHF
COPD/CHF/Cirrhosis
3
14
$25-$50k
0
9,246
5,969.9688
null
10
white
13.398438
16
0.891968
0.81897
1
0
0
no
0.9
0.6
no dnr
6
80
9.298828
80
20
37.09375
357.125
null
0.399963
1.299805
137
7.469727
null
null
null
0
null
no(M2 and SIP pres)
0.4948
758
63.017
0
male
0
14
1,374
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
$25-$50k
26
133,878
63,155.6875
null
16.666656
white
20.5
25
0.759888
0.68396
5
0
0
no
0.8
0.7
no dnr
14
57
6.899414
80
8
37.19531
144
2.599609
0.899902
0.899902
137
7.449219
null
null
null
0
null
null
0.4948
759
41.974
0
male
0
53
1,373
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
328,134
null
null
35.5
white
53.695313
73
0.21698
0.120987
1
0
0
no
0.4
0.4
no dnr
53
50
5.699219
135
30
35.09375
56
2.799805
5.599609
3.099609
142
7.40918
null
null
null
null
null
null
2.099609
760
67.88495
1
male
1
24
24
ARF/MOSF w/Sepsis
ARF/MOSF
0
18
$25-$50k
26
181,177
83,650.4375
null
25
white
24.597656
33
0.664917
0.567993
4
0
0
no
0.5
0.5
no dnr
24
73
25.796875
110
22
36.39844
230
2.799805
1.799805
1.399902
131
7.449219
null
null
null
null
null
<2 mo. follow-up
2.439941
761
46.48297
0
female
0
16
1,373
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
37
95,454
46,194.7812
null
17.333328
white
22.398438
35
0.759888
0.68396
5
0
0
no
0.7
0.7
no dnr
16
75
10.298828
130
48
38
427
null
null
0.799927
141
7.30957
null
null
null
null
null
no(M2 and SIP pres)
2.946777
762
64.51697
1
male
0
17
249
CHF
COPD/CHF/Cirrhosis
2
9
under $11k
0
125,379
72,966.375
null
24.666656
white
21.597656
22
0.809937
0.692993
6
0
0
no
null
null
no dnr
17
67
8.398438
100
24
36
null
null
null
1.299805
129
null
null
null
null
0
null
SIP>=30
0.4948
763
65.711
1
female
0
44
394
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
>$50k
0
497,053
228,884.625
null
38.75
white
37.59375
60
0.422974
0.302979
9
0
0
no
null
null
no dnr
44
50
13.699219
95
12
38.5
106.65625
3.599609
2.399902
5
144
7.5
null
null
null
null
0
null
0
764
73.42896
1
male
0
14
413
CHF
COPD/CHF/Cirrhosis
1
12
>$50k
0
79,641
39,536.7812
null
30
white
26.097656
33
0.745972
0.599976
1
0
0
no
null
null
no dnr
14
53
19.398438
80
20
36.39844
155.09375
null
null
1.399902
137
7.259766
null
null
null
null
1
null
1
765
34.05899
0
female
0
36
1,368
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
under $11k
0
250,630
105,455.062
null
23.25
black
22.199219
11
0.895996
0.85791
2
0
0
no
0.95
0.9
no dnr
36
103
21.898438
105
18
38.79688
257.5
null
null
0.5
133
7.469727
null
null
null
null
0
no(M2 and SIP pres)
0
766
32.40198
1
female
1
18
18
MOSF w/Malig
ARF/MOSF
2
17
$25-$50k
44
262,612
123,059.438
null
33.666657
white
46.59375
69
0.007999
0.001
12
0
0
yes
null
null
dnr after sadm
8
107
13.099609
120
28
36.79688
142.5
null
36
3.899902
142
7.509766
null
null
null
null
0
<2 mo. follow-up
0
767
28.30099
0
male
0
37
1,366
CHF
COPD/CHF/Cirrhosis
1
null
null
0
194,198
119,175.312
null
15.5
white
22.097656
30
0.924927
0.872925
1
0
0
no
null
null
no dnr
37
67
6.299805
135
16
36.29688
null
null
null
1.599854
139
null
null
null
null
null
null
null
2.690918
768
56.323
1
male
1
3
3
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
100
151,266
68,650.875
null
32
white
73.1875
82
0
0
14
1
0
no
null
null
no dnr
3
0
15.398438
135
10
38.5
142
null
null
3.199707
132
7.469727
null
null
null
null
null
<2 mo. follow-up
2.596191
769
47.98099
0
female
0
4
1,364
Lung Cancer
Cancer
2
18
null
0
null
null
null
9
white
16.5
12
0.754883
0.497986
1
0
0
metastatic
null
null
null
null
72
8.298828
100
20
37.19531
null
null
null
0.799927
136
null
null
null
null
null
null
no(M2 and SIP pres)
2.524902
770
70.125
1
female
1
11
11
Coma
Coma
0
null
null
55
96,471
46,450.0938
null
40.5
white
30
47
0.210999
0.148987
1
0
0
no
null
null
dnr after sadm
9
122
37
135
28
38.5
113.32812
null
null
1.199951
140
7.539062
null
null
null
null
null
<2 mo. follow-up
2.359863
771
35.31799
1
female
1
18
18
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
37
212,409
97,678.0625
null
35.666657
black
33.898438
36
0.609985
0.503906
2
0
0
no
null
null
no dnr
18
70
11
130
22
38.89844
37
null
1.199951
0.799927
134
7.199219
null
null
null
null
null
<2 mo. follow-up
2.666016
772
52.827
1
male
1
8
8
ARF/MOSF w/Sepsis
ARF/MOSF
4
14
>$50k
44
116,166
56,024.5312
null
29.5
white
39.695313
74
0.232971
0.132996
7
0
0
no
null
null
dnr after sadm
6
53
12.398438
110
24
39.5
null
null
25.597656
7.799805
145
null
null
null
null
null
7
<2 mo. follow-up
7
773
68.64899
1
male
0
20
45
CHF
COPD/CHF/Cirrhosis
5
18
$11-$25k
0
75,142
37,775.2188
null
15.666664
white
35
50
0.578979
0.384949
1
0
0
no
0.75
0.6
no dnr
20
65
20.796875
120
30
35.79688
253.03125
null
0.5
3.299805
127
7.429688
null
null
null
0
null
<2 mo. follow-up
0.4948
774
69.52795
0
male
0
14
1,361
ARF/MOSF w/Sepsis
ARF/MOSF
3
17
>$50k
26
122,312
61,386.375
null
17.333328
white
25.898438
39
0.598999
0.490967
8
0
0
no
null
null
no dnr
14
68
19.398438
110
40
39.5
295
2.199707
0.399963
0.599976
131
7.549805
null
null
null
null
0
SIP>=30
0
775
63.05798
1
male
0
71
1,016
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
37
600,192
274,269.75
null
45.5
white
32.695313
62
0.41095
0.291992
6
1
0
no
null
null
no dnr
71
52
10.699219
120
38
39.09375
198
null
null
2.099609
140
7.449219
null
null
null
null
null
null
3.199707
776
66.09198
1
male
0
4
54
Lung Cancer
Cancer
1
18
>$50k
0
8,272
3,430.8106
null
11
asian
17
11
0.704956
0.419983
1
0
0
metastatic
0.75
0.25
no dnr
4
83
6.299805
90
20
36.59375
null
null
null
0.799927
132
null
null
null
null
0
null
<2 mo. follow-up
0.4948
777
70.48297
1
female
0
9
670
CHF
COPD/CHF/Cirrhosis
2
16
null
0
19,065
10,006.6484
null
13.5
white
24.199219
31
0.78894
0.661987
1
0
0
no
0.75
0.6
no dnr
9
53
6.899414
110
22
36.19531
null
null
1
0.899902
134
null
null
null
null
null
1
null
1
778
60.98599
1
female
0
82
433
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
26
864,424
null
null
32.75
white
19.699219
33
0.684937
0.591919
49
0
0
yes
null
null
no dnr
82
70
8.298828
115
26
38.19531
187.5
2.299805
0.799927
0.899902
136
7.5
null
null
null
null
null
null
2.479981
779
85.862
1
female
1
57
57
COPD
COPD/CHF/Cirrhosis
1
null
$11-$25k
0
329,169
131,754.125
null
30.75
white
33.898438
52
0.396973
0.199982
1
0
0
no
null
null
dnr after sadm
2
128
11.298828
155
14
36.19531
155
2.699707
null
1.799805
137
7.469727
null
null
null
null
null
<2 mo. follow-up
3.770508
780
59.81097
1
female
0
63
232
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
44
401,801
180,741.5
null
34.75
black
30.097656
47
0.471985
0.352966
6
0
0
no
0.15
0.1
no dnr
63
93
28.296875
140
30
38.5
147.5
1.799805
0.699951
0.799927
129
7.469727
null
null
null
null
6
adl>=4 (>=5 if sur)
6
781
56.65399
0
female
0
15
1,355
Colon Cancer
Cancer
1
12
$25-$50k
0
61,711
29,678.0781
null
24.666656
black
8.699219
20
0.910889
0.792969
1
0
0
metastatic
0.8
0.7
no dnr
15
80
6.799805
116
24
38.39844
null
3.599609
4.699219
0.899902
136
null
null
null
null
null
null
no(M2 and SIP pres)
2.257324
782
82.086
0
male
0
7
1,354
CHF
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
22,899
11,851.4297
null
12.5
other
27.199219
46
0.67688
0.506958
1
0
0
no
null
null
no dnr
7
55
6.799805
120
24
36.29688
null
null
null
2.099609
135
null
null
null
null
null
null
no(M2 and SIP pres)
3.915039
783
33.5
0
female
0
33
1,353
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
158,358
76,204.125
null
11.5
hispanic
20
26
0.912964
0.880981
2
0
0
no
0.95
0.9
no dnr
33
117
15.699219
76
34
36.19531
280
1.599854
0.199982
0.899902
130
7.379883
null
null
null
5
0
SIP>=30
0
784
72.84094
1
male
0
4
541
Lung Cancer
Cancer
1
null
null
0
10,314
5,952.375
null
9
white
18.699219
15
0.652954
0.347961
1
0
0
metastatic
0.9
0.7
no dnr
4
87
5.5
80
18
36
null
null
1.099854
1.099854
129
null
null
null
null
null
null
null
2.465332
785
78.43695
1
female
1
12
12
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
null
61
106,126
48,244.8438
null
45.5
white
29.199219
34
0.313965
0.200989
3
0
0
no
0.3
0.2
no dnr
12
67
11.199219
60
24
38.39844
71.26562
null
0.799927
1
128
7.329102
null
null
null
null
null
<2 mo. follow-up
3.557617
786
78.00995
1
male
0
52
969
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
26
298,193
133,595.625
null
25.75
white
20.296875
31
0.671997
0.575928
11
0
0
no
null
null
no dnr
52
70
7.799805
110
34
38.69531
267.5
null
null
0.899902
130
7.459961
null
null
null
null
null
null
2.775879
787
67.92596
1
female
0
11
1,000
Colon Cancer
Cancer
1
12
null
0
30,406
15,743.8906
null
19
white
11.599609
24
0.873901
0.715942
1
0
0
metastatic
0.95
0.8
no dnr
11
108
28.199219
108
20
36.59375
null
3.299805
2.099609
0.699951
137
null
null
null
null
null
null
null
2.393555
788
68.55597
1
male
0
5
923
CHF
COPD/CHF/Cirrhosis
3
14
$25-$50k
0
11,855
6,571.6523
null
8
white
21
23
0.839966
0.737915
1
0
0
no
null
null
no dnr
5
93
7.699219
100
22
35.89844
295.1875
null
null
1.899902
139
7.429688
null
null
null
null
null
null
2.421875
789
68.68195
1
male
0
5
222
Lung Cancer
Cancer
1
12
$11-$25k
0
8,686
4,529.3477
null
8
white
25.398438
29
0.491943
0.172974
1
0
0
metastatic
null
null
no dnr
5
83
1.599854
100
24
36.39844
null
3
0.599976
2
138
null
null
null
null
null
null
null
2.617188
790
33.01297
1
female
0
12
68
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
26
77,603
40,723.6875
null
23
white
23
55
0.845947
0.792969
2
1
0
no
0.9
0.8
no dnr
12
133
10.5
100
8
38.19531
194
null
0.5
10.798828
146
7.439453
null
null
null
null
null
null
2.748535
791
55.96399
0
male
0
22
1,346
Cirrhosis
COPD/CHF/Cirrhosis
4
14
$25-$50k
0
193,362
100,574.375
null
20.666656
white
22
26
0.671997
0.5
7
0
0
yes
0.8
0.6
no dnr
22
77
12.898438
110
24
39
null
null
3.699707
0.899902
146
null
null
null
null
null
1
no(M2 and SIP pres)
1
792
79.45496
1
female
0
6
636
CHF
COPD/CHF/Cirrhosis
2
16
>$50k
0
13,703
8,028.125
null
6
white
17.898438
16
0.841919
0.73999
1
0
0
no
null
null
no dnr
6
80
6.5
50
16
36.29688
null
null
null
1.199951
137
null
null
null
null
1
null
no(M2 and SIP pres)
1.1669
793
60.37198
0
male
0
20
1,344
ARF/MOSF w/Sepsis
ARF/MOSF
0
18
$25-$50k
37
234,608
110,586.75
null
33.333313
white
17.398438
40
0.780884
0.709961
7
0
0
no
0.85
0.85
no dnr
20
132
7.799805
110
10
38.39844
272.6875
2
3
1.199951
136
7.459961
null
null
null
null
0
null
0
794
71.65796
1
female
1
28
28
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
37
477,929
214,188.625
null
41.5
white
36.195313
55
0.197998
0.105988
33
0
0
no
null
null
dnr after sadm
24
52
14
110
12
36.89844
152
null
null
4.199219
143
7.459961
null
null
null
null
null
<2 mo. follow-up
2.786133
795
95.66095
1
female
0
5
661
CHF
COPD/CHF/Cirrhosis
1
10
null
9
12,435
6,208.4922
null
14
white
17.796875
31
0.756958
0.615967
1
0
0
no
null
null
no dnr
5
89
11.599609
84
36
38
262.9375
3.199707
0.799927
1.099854
144
7.419922
null
null
null
null
4
null
4
796
61.88098
1
male
1
55
55
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
44
777,314
365,120.5
null
48.25
white
37.195313
78
0.197998
0.105988
38
0
0
no
0.5
0.5
dnr after sadm
31
60
19.796875
140
30
39
114
2.199707
1.199951
2.799805
131
7.239258
null
null
null
null
null
<2 mo. follow-up
3.333496
797
72.35297
1
female
1
3
3
CHF
COPD/CHF/Cirrhosis
1
13
$11-$25k
100
25,184
11,041.5938
null
39
white
38.398438
40
0.037994
0.003
1
0
0
no
null
null
no dnr
3
48
7.299805
0
12
37.19531
388
3.199707
1.299805
1.399902
129
7.449219
null
null
null
null
null
<2 mo. follow-up
3.769531
798
57.93597
1
male
1
8
8
Cirrhosis
COPD/CHF/Cirrhosis
3
null
null
0
29,521
16,122.7266
null
16.5
white
30.398438
55
0.598999
0.408997
1
0
0
no
0.3
0.1
dnr after sadm
4
73
11.798828
108
20
36.59375
523.75
2.299805
11.798828
1.599854
130
7.429688
null
null
null
null
null
<2 mo. follow-up
3.885254
799
47.82498
1
male
0
12
889
Cirrhosis
COPD/CHF/Cirrhosis
4
14
under $11k
0
29,605
17,551.2656
null
12.5
white
15.898438
10
0.889893
0.815918
1
0
0
no
null
null
no dnr
12
84
2.899902
80
16
35.59375
380
2.799805
0.399963
0.799927
140
7.439453
null
null
null
0
null
null
0.4948
800
70.14899
1
male
0
5
684
CHF
COPD/CHF/Cirrhosis
2
null
null
0
12,331
7,431.0938
null
10
white
15.898438
17
0.886963
0.810913
1
0
0
no
null
null
no dnr
5
73
7.599609
90
18
36
null
null
1.099854
1.099854
140
null
null
null
null
null
null
null
2.080078